SpaceX (SPCX) closes up 19% on its first trading day — the largest IPO in history debuts strong, setting the comparable for Anthropic and OpenAI
TL;DR: SpaceX began trading on Nasdaq under SPCX on June 12, 2026. Shares opened at $150 (above the $135 IPO price), peaked at $176.52 intraday (+31%), and closed at $160.95 — up 19% from the offer. Market cap ~$1.77 trillion on ~$75 billion raised: the largest IPO in history, confirmed across CNBC, NPR, Yahoo Finance, and CNN. Because xAI sits inside SpaceX (February 2026 all-stock buyout), public-market investors now hold the first frontier-AI-lab exposure in a listed company. The structural read for our beat: a strong debut is a constructive pricing precedent for the Anthropic and OpenAI listings expected later in 2026 — but the same-week Fable 5 government shutdown is a sharp reminder that a pure AI lab carries regulatory tail risk a rocket-and-satellites business does not.
The numbers
Confirmed across CNBC, NPR, Yahoo Finance, and CNN:
- IPO price: $135 (fixed roadshow price)
- Open: $150
- Intraday high: $176.52 (~+31% from offer)
- Close: $160.95 (+19% from offer)
- Amount raised: ~$75 billion — largest IPO ever
- Market cap at close: ~$1.77 trillion
- Ticker / venue: SPCX on Nasdaq
The $135 offer was the syndicate’s allocation price, as we flagged in the pricing-day coverage. June 12 was the real price discovery — and the market marked it up 19%.
What public investors actually bought
SPCX bundles four businesses into one ticker:
- Rockets — Falcon 9, Falcon Heavy, Starship
- Starlink — 9M+ subscribers
- xAI / Grok — frontier AI lab, merged in via the February 2026 all-stock buyout at a $250B valuation
- Colossus / Colossus 2 — gigawatt-scale Memphis data centers
The xAI inclusion is what makes this our story. There is no standalone xAI security; SPCX is the only public-market route to Grok exposure. And as a public subsidiary, xAI’s revenue, user counts, and compute costs become quarterly-disclosable — ending the opacity that’s made Grok the least financially transparent frontier lab.
Why this matters for the AI IPO race
Three reads.
1. The comparable landed on the bullish side. We framed the day-one reception as the signal that would shape Anthropic and OpenAI pricing. A 19% close — healthy, not frothy — is about the best outcome bankers could want: clear demand without the 50%+ pop that screams underpricing. It argues for confidence in pricing the AI-lab listings near the top of their ranges.
2. But SPCX is a diversified comparable, and that caveat just got louder. SpaceX’s AI exposure is one leg of a four-leg business. A pure-play AI lab is a different risk object — as the same-week Fable 5 / Mythos 5 government shutdown demonstrated in the starkest possible terms. SpaceX doesn’t have a flagship product a national-security authority can pull offline overnight; Anthropic just learned that it does. Investors pricing the AI-lab IPOs will discount for exactly that regulatory tail risk, and SPCX’s clean debut doesn’t neutralize it.
3. Retail’s 30% allocation will drive volatility from here. The unusually high 30% retail share ($22.5B) means SPCX’s price action will be more retail-sentiment-driven than a typical mega-cap. Expect bigger swings than the fundamentals alone justify over the first weeks — useful to remember before reading too much into any single day’s move as an AI-IPO omen.
What it means for Grok and the AI tools market
For Grok users: nothing operationally changes — SuperGrok, X Premium, and Grok’s coding tools are unaffected by the listing.
For AI-exposure investors: SPCX is now the most liquid AI-adjacent public security, with the diversification of Starlink and launch revenue layered on top of frontier-AI upside.
For the Anthropic/OpenAI listing timeline: the demand signal is green, the risk-discount signal is amber. Watch whether the AI labs accelerate or pause their roadshows now that they have both a strong comparable and a fresh regulatory cautionary tale in the same week.
The honest caveats
One day is not a trend. A 19% close is a strong open, but lockups, the next earnings print, and macro conditions will matter far more to where SPCX trades in six months.
The xAI valuation inside SPCX is not separately disclosed. Whether the February $250B xAI mark is preserved or implicitly re-rated within the $1.77T total isn’t transparent — SPCX is bundled exposure, not a pure-play.
Correlating SPCX to the AI-lab IPOs is inference, not fact. The comparison is reasonable, but SpaceX’s business mix, Musk-specific retail dynamics, and the same-week Anthropic news all muddy a clean read-across.
What it changes for Pick Right readers
For Grok subscribers, nothing today. For anyone tracking the AI IPO race, June 12 delivered the data point we were waiting on — a constructive one — immediately complicated by the Fable 5 shutdown a few hours later. The two stories together are the most honest summary of the moment: public-market appetite for AI is strong, and the regulatory ground under frontier labs is shifting fast.
For broader context, see the SpaceX pricing-day coverage, the Grok review, the Anthropic S-1 filing, the OpenAI S-1 filing, and the Fable 5 government shutdown article.
Frequently asked questions
How did SpaceX stock do on its first day?
SPCX opened at $150 — above the $135 IPO price — peaked at $176.52 intraday (a ~31% gain), and closed at $160.95, up 19% from the offer price. That put SpaceX's market cap at roughly $1.77 trillion on its first trading day.
Can I buy xAI stock directly?
No — there is no standalone xAI security. xAI was absorbed into SpaceX in a February 2026 all-stock buyout, so buying SPCX is the only public-market way to hold xAI/Grok exposure, bundled with the rocket and Starlink businesses.
What does the SpaceX IPO mean for Anthropic and OpenAI?
It's a constructive pricing precedent. A 19% first-day gain on the largest IPO ever signals strong public-market appetite for AI-adjacent technology, which helps bankers price the Anthropic and OpenAI listings expected later in 2026. The caveat: pure AI labs carry regulatory tail risk — underscored by Anthropic's same-week Fable 5 shutdown — that SpaceX's diversified business does not.
Is a 19% first-day pop good or a sign of underpricing?
Both readings exist. A 19% gain is a healthy, confidence-building debut that's well short of the speculative 50%+ pops that signal severe underpricing. The $135 offer was a fixed roadshow price; the $160.95 close is the market's first real price-discovery mark.
Sources
Related tool reviews
Questions or corrections? Email Pick Right. Want the full list? See all news.